| Date Filed | Type | Description |
| 05/18/2023 |
4
| Lucera Erick (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 77,900 shares
@ $0
Granted 155,800 options to buy
@ $9.61, valued at
$1.5M
|
|
| 05/18/2023 |
3
| Lucera Erick (EVP, CFO) has filed a Form 3 on Editas Medicine, Inc. |
| 04/05/2023 |
4
| Lucera Erick (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.465, valued at
$11.6k
|
|
| 04/05/2023 |
3
| Lucera Erick (Director) has filed a Form 3 on SAB Biotherapeutics, Inc. |
| 03/31/2023 |
4
| Lucera Erick (Director) has filed a Form 4 on Beyond Air, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.28, valued at
$251.2k
|
|
| 03/20/2023 |
4
| Lucera Erick (Director) has filed a Form 4 on Beyond Air, Inc.|
Txns:
| Bought 2,000 shares
@ $6.817, valued at
$13.6k
|
|
| 03/08/2023 |
4
| Lucera Erick (Director) has filed a Form 4 on Bone Biologics Corp|
Txns:
| Granted 36,845 options to buy
@ $1.61, valued at
$59.3k
|
|
| 01/19/2023 |
4
| Lucera Erick (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 50,000 options to buy
@ $6.7, valued at
$335k
Disposed/sold 100,000 options to buy
@ $9.12, valued at
$912k
Disposed/sold 218,800 options to buy
@ $3.67, valued at
$803k
|
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Lucera Erick (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.|
Txns:
| Granted 218,800 options to buy
@ $3.67, valued at
$803k
|
|
| 10/21/2021 |
3
| Lucera Erick (Director) has filed a Form 3 on Bone Biologics Corp |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2020 |
4
| Lucera Erick (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Granted 500,000 options to buy
@ $0.67, valued at
$335k
|
|
| 01/08/2020 |
3
| Lucera Erick (CFO) has filed a Form 3 on AVEO PHARMACEUTICALS INC |
| 03/08/2019 |
4
| Lucera Erick (See Remarks) has filed a Form 4 on Valeritas Holdings Inc.|
Txns:
| Granted 280,000 options to buy
@ $0.43, valued at
$120.4k
|
|
| 11/20/2018 |
4
| Lucera Erick (See Remarks) has filed a Form 4 on Valeritas Holdings Inc.|
Txns:
| Granted 363,000 options to buy
@ $0.41, valued at
$148.8k
|
|
| 08/15/2018 |
4
| Lucera Erick (Director) has filed a Form 4 on AIT Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.25, valued at
$106.3k
|
|
| 04/30/2018 |
4
| Lucera Erick (Director) has filed a Form 4 on AIT Therapeutics, Inc.|
Txns:
| Bought 1,171 options to buy
@ $4.25, valued at
$5k
Exercised 1,171 options to buy
@ $4.25, valued at
$5k
|
|
| 04/30/2018 |
3
| Lucera Erick (Director) has filed a Form 3 on AIT Therapeutics, Inc. |
| 02/15/2018 |
4
| Lucera Erick (See Remarks) has filed a Form 4 on Valeritas Holdings Inc.|
Txns:
| Granted 27,000 options to buy
@ $3.07, valued at
$82.9k
|
|
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2017 |
4
| Lucera Erick (CFO) has filed a Form 4 on Valeritas Holdings Inc.|
Txns:
| Bought 3,000 shares
@ $10, valued at
$30k
Granted 73,800 options to buy
@ $7.12, valued at
$525.5k
|
|
| 03/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |